Healthcare / Medical Care FacilitiesSES
$0.01
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $353000.00 · quality 25.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
22/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11M
P/E
N/A
•EV/EBITDA
15.2x
↑ROE
4.5%
↑Gross Margin
56.1%
↑Debt/Equity
1.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-3.6%
FCF CAGR
—
FCF margin
-12.6%
FCF / Net income
-25.65x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.4M · net income $46000.0 · FCF $-1.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.4M | $9.4M | $5.9M | $8.0M | $10.5M |
| Net Income | $46000.00 | $46000.00 | $-4.9M | $-2.2M | $-2.1M |
| EBITDA | $740000.00 | $740000.00 | $-4.5M | $-886000.00 | $-266000.00 |
| EPS | — | — | -0.01 | -0.00 | -0.01 |
| Gross Margin | 56.1% | 56.1% | 52.1% | 54.7% | 54.6% |
| Operating Margin | -3.1% | -3.1% | -49.9% | -30.2% | -22.0% |
| Net Margin | 0.5% | 0.5% | -83.6% | -27.6% | -20.1% |
| Balance Sheet | |||||
| Debt/Equity | 1.40 | 1.40 | -0.42 | 21.79 | -3.33 |
| Current Ratio | 1.01 | 1.01 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.2M | $-1.2M | $1.6M | $353000.00 | $-833000.00 |
| Returns | |||||
| ROE | 4.5% | 4.5% | 110.2% | -1667.7% | 159.4% |
| Valuation | |||||
| EV/EBITDA | 15.17 | 15.17 | — | — | — |
| P/B | 10.12 | 10.12 | — | 168.95 | — |
| Growth & Yield | |||||
| Revenue Growth | 59.7% | 59.7% | -26.8% | -23.5% | — |
| EPS Growth | — | — | -63.3% | 9.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-35.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → n/d
Residual
-35.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.